This is not just a disease of the elderly, with 22% of survivors under age 50, and 67% under age 70. The rise in younger stroke patients reflects increases in hypertension, cholesterol, diabetes, and other underlying health issues.
Huge Economic Burden: The negative impact on healthcare, productivity, and employment costs global society $450 billion, and, in the US, costs exceed $50 billion annually (CDC statistics). One in four adults will suffer a stroke in their lifetime.
Current neural-rehabilitation therapies (repetitive physical exercises, brain stimulation, and others) are statistically proven to work, but the clinical results are limited. Most patients still have mobility, speech, cognition, or other serious impairments, resulting in lower quality of life and/or loss of functional independence.